1. New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy

   • Maria Fleseriu
   • Stephan Petersenn

   Topic Review Open access 15 May 2013 Pages: 1 - 11

   

2. MicroRNA biomarkers in glioblastoma

   • Simon Kjær Hermansen
   • Bjarne Winther Kristensen

   Topic Review 23 May 2013 Pages: 13 - 23

   

3. Caloric restriction reduces edema and prolongs survival in a mouse glioma model

   • Yong-Sheng Jiang
   • Fu-Rong Wang

   Laboratory Investigation 24 May 2013 Pages: 25 - 32

   

4. Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model

   • Valerie L. Jacobs
   • Joyce A. De Leo

   Laboratory Investigation 22 May 2013 Pages: 33 - 42

   

5. Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition

   • Gerald C. Wallace IV
   • Catherine P. Haar
   • Arabinda Das

   Laboratory Investigation 11 June 2013 Pages: 43 - 50

   

6. Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from neuritin

   • Zhao Yang
   • Tianzhi Zhao
   • Qingwu Yang

   Laboratory Investigation Open access 11 June 2013 Pages: 51 - 58

   

7. Glutamine synthetase functions as a negative growth regulator in glioma

   • Ying Yin
   • Weifeng Sun
   • Chunxing Liu

   Laboratory Investigation 19 June 2013 Pages: 59 - 69

   

8. Sluggish cognitive tempo in survivors of pediatric brain tumors

   • Victoria W. Willard
   • Kristina K. Hardy
   • Melanie J. Bonner

   Clinical Study 10 May 2013 Pages: 71 - 78

9. Prediagnostic body weight and survival in high grade glioma

   • Erin M. Siegel
   • L. Burton Nabors
   • Kathleen M. Egan

   Clinical Study 11 May 2013 Pages: 79 - 84

   

10. Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience

    • J. S. Frenel
    • C. Leux
    • M. Campone

    Clinical Study 17 May 2013 Pages: 85 - 91

    

11. Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial

    • Chiara Zucchella
    • Annarita Capone
    • Michelangelo Bartolo

    Clinical Study 16 May 2013 Pages: 93 - 100

    

12. Early and late postoperative seizure outcome in 97 patients with supratentorial meningioma and preoperative seizures: a retrospective study

    • Zhe Zheng
    • Peng Chen
    • Jianmin Zhang

    Clinical Study 24 May 2013 Pages: 101 - 109

13. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide

    • Krishna Reddy
    • Laurie E. Gaspar
    • Changhu Chen

    Clinical Study 02 June 2013 Pages: 111 - 116

    

14. Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer

    • Saurabh Ray
    • Stacey Dacosta-Byfield
    • April Teitelbaum

    Clinical Study 23 May 2013 Pages: 117 - 125

    

15. MR perfusion in and around the contrast-enhancement of primary CNS lymphomas

    • Stella Blasel
    • Alina Jurcoane
    • Elke Hattingen

    Clinical Study 22 May 2013 Pages: 127 - 134

    

16. O⁶-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma

    • Xiaoyin Jiang
    • David A. Reardon
    • Henry S. Friedman

    Clinical Study 18 May 2013 Pages: 135 - 140

17. Adult primitive neuroectodermal tumors: the prognostic value of supratentorial location

    • Rikesh Gandhi
    • Ranjith Babu
    • Cory Adamson

    Clinical Study 30 May 2013 Pages: 141 - 148

    

18. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme

    • R. M. Bambury
    • M. Y. Teo
    • S. O’Reilly

    Clinical Study 19 June 2013 Pages: 149 - 154